Pillar5 Pharma Inc.

Form 483 issued December 15, 2023 · Arnprior, Canada

Inspection
Dec 7 – Dec 15, 2023
Investigator
Saundrea A. Munroe
Observations
3
Pages
6
FEI number
3000241849

In short: On December 15, 2023, FDA issued a Form 483 with 3 observations to Pillar5 Pharma Inc. in Arnprior, Ontario (FEI 3000241849) after an inspection that ran Dec 7 – Dec 15, 2023. The investigator was Saundrea A. Munroe. Most observations concern production and quality system.

At a glance

Production and quality system account for 2 of 3 observations.

Production1
Quality system1
Materials1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include…

  2. 02

    Written records are not always made of…

  3. 03

    Establishment of the reliability of the container and closure supplier's report of analyses is deficient in…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Pillar5 Pharma Inc.?

FDA listed 3 observations on this Form 483, mostly about production, quality system and materials. The opening words of each observation are shown on this page.

Who inspected Pillar5 Pharma Inc.?

Saundrea A. Munroe is named on this Form 483, for the inspection of Dec 7 – Dec 15, 2023. Each investigator has a profile showing what they cite most.

When was Pillar5 Pharma Inc. inspected by FDA?

The inspection ran Dec 7 – Dec 15, 2023, and the Form 483 is dated December 15, 2023.

How do I get the full Form 483 for Pillar5 Pharma Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free